Kyverna Therapeutics, Inc. KYTX Capitalized software write-off
Capitalized software write-off at other companies
Other financials
Where this comes from
Reported directly by Kyverna Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CapitalizedComputerSoftwareImpairments1.
The official record: Kyverna Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kyverna Therapeutics, Inc.'s capitalized software write-off.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kyverna Therapeutics, Inc.'s capitalized software write-off?
- Kyverna Therapeutics, Inc. (KYTX) reported capitalized software write-off of $0 in Q1 2026.
- What does capitalized software write-off mean?
- This represents the write-down of the carrying value of capitalized software assets when their fair value falls below their book value. It indicates that previously invested development costs are no longer expected to provide the anticipated economic benefits. High or recurring impairments may signal inefficiencies in the company's software development or technology strategy.